Gene Therapy Targeting Monocyte Chemoattractant Protein-1 For Vascular Disease
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-12-01
著者
-
Egashira Kensuke
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
-
Kitamoto Shiro
Department of Cardiovascular Medicine, Kyushu University Graduate School of Medicine
-
Egashira Kensuke
Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University
-
Kitamoto Shiro
Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University
-
Kitamoto Shiro
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
関連論文
- OJ-212 Nanoparticle-Mediated Intracellular Delivery of Pitavastatin to Endothelial Progenitor Cells Ex Vivo Recovers the Functional Activity for Therapeutic Neovascularization(OJ36,Peripheral Circulation/Vascular Disease (Therapy) 2 (H),Oral Presentation
- FRS-016 Nanoparticle-Mediated Endothelial Cell-Selective Delivery of Pitavastatin Induces Functional Collateral Arteries (Therapeutic Arteriogenesis) in a Rabbit Model of Chronic Hindlimb Ischemia(FRS4,Topics in Peripheral Arterial Disease (H),Featured Re
- PJ-336 Pitavastatin Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis, and Prevents Adverse Effects of Silorimus-Eluting Cypher Stent in Porcine Coronary Artery Model(PJ057,Translational Science (Cardiac) (H),Poster Session (Japanese),T
- Pulmonary Capillary Hemangiomatosis With Severe Pulmonary Hypertension
- FRS-073 Cardiac 12-lipoxygenase-induced Inflammation is Involved in Heart Failure(FRS15,Novel Molecular Mechanisms of Heart Failure 1 (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-293 Mechanisms Underlying Coronary Vasopsasm at Distal Arterial Segments of Sirolimus-Eluting Stent Implantation in a Porcine Model(OE50,Coronary Circulation/Chronic Coronary Disease (Basic/Clinical) (IHD),Oral Presentation (English),The 73rd Annual Sc
- OE-059 Cholesterol-lowering Therapy with the Cholesterol Absorption Inhibitor Ezetimibe Inhibits Plaque Destabilization and Rupture in the Brachiocephalic Arteries of ApoE-deficient Mice(OE10,Atherosclerosis, Basic 1 (IHD),Oral Presentation (English),The
- Essential Role of Angiotensin II Type 1a Receptors in the Host Vascular Wall, but Not the Bone Marrow, in the Pathogenesis of Angiotensin II-Induced Atherosclerosis
- PJ-375 Nanoparticle-Mediated Intracellular Delivery of Imatinib, a PDGF-Receptor Tyrosine Kinase Inhibitor, in Porcine Coronary Arteries from Nanoparticle-Eluting Stent Attenuates Neointimal Formation(Restenosis basic/clinical(04)(IHD),Poster Session(Japa
- PJ-170 Blockade of NF-κB by Nano-DDS of NF-κB decoy to the lung ameliorates monocrotaline-induced Pulmonary Arterial Hypertension(Pulmonary circulation(03)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-222 Nanoparticle-Mediated Delivery of HMG-CoA Reductase Inhibitor (statin)from Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis in Porcine Coronary Arteries in Vivo(Restenosis basic / clinical(02)(IHD),Oral Presentation (Japanese),The 72nd Annua
- OE-188 Monocyte-targeting Nanoparticle-based Delivery of Pioglitazone Inhibits Plaque Rupture in the Brachiocephalic Arteries of Apolipoprotein-E Deficient Mice(Atherosclerosis, basic(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting
- FRS-029 Monocyte-Targeting Nanoparticle-Based Delivery of Anti-Monocyte Chemoattractant Protein-1 Gene Inhibits Plaque Rupture of Brachiocephalic Arteries in Apolipoprotein-E Deficient Mice(Novel Mechanisms in Atherosclerosis (IHD),Featured Research Sessi
- 4 Single Intratracheal Administration of Bioabsorbable Nanoparticle Incorporated with Statin Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Survival(Young Investigator's Award for International Students Finalists Lecture (YIA Intern
- PJ-326 Intracellular Delivery of Imatinib (PDGF Receptor Tyrosine Kinase Inhibitor) with Bioabsorbable Polymeric Nanoparticle Technology Effectively Suppresses Vein Graft Neointima Formation(Cardiovascular surgery/CABG-2, The 71st Annual Scientific Meetin
- PE-334 Parallel Increases in LV End-systolic Elastance and Arterial Elastance in Elderly Japanese with Hypertension Make Apparent Systolic Function Normal(Echo/Doppler-12, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-130 Blockade of Vascular Endothelial Cell Growth Factor by Catheter-Based Adenovirus-Mediated Gene Therapy Attenuates In-Stent Neointima Formation in Cynomolgus Monkeys(Atherosclerosis, basic-7, The 71st Annual Scientific Meeting of the Japanese Circul
- PE-037 An Essential Role of Angiotensin II Type 1 Receptor in Arterial Wall, Not in Bone Marrow, in Angiotensin II-Induced Atherosclerosis(Atherosclerosis, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-177 A Novel Nanotechnology-Based Strategy for Therapeutic Neovascularization : Local Delivery of Statin with Biodegradable-Polymeric-Nanoparticle Improves Therapeutic Efficacy of Ischemic Neovascularization(Regeneration (angiogenesis / myocardial regen
- OJ-081 Sustained Intracellular Delivery of Nanoparticles in Porcine Coronary Arteries from a Bioabsorbable Polymeric Nanoparticle-Eluting Stent(Coronary revascularization, PCI-05, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-646 A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Inhibits Migration/Proliferation of Vascular Smooth Muscle Cells through Suppression of MCP-1 Release(Cardiovascular pharmacology, basic/clinical-5 (H) PJ109,Poste
- OJ-189 Feasibility of Biodegradable Polymeric Nanoparticle Technology for Intracellular Drug Delivery as a Novel Treatment of Vein Graft Disease(Cardiovascular surgery/CABG-1 (IHD) OJ32,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific M
- Angiotensin-Converting Enzyme Activity is Involved in the Mechanism of Increased Endogenous Nitric Oxide Synthase Inhibitor in Patients With Type 2 Diabetes Mellitus
- Angiotensin-Converting Enzyme Activity is Involved in the Mechanism of Increased Endogenous Nitric Oxide Synthase Inhibitor in Type II Diabetes Mellitus
- Renin-Angiotensin System is Involved in the Mechanism of Increased Serum Asymmetric Dimethylarginine in Essential Hypertension
- Stromal Cell-Derived Factor-1α Gene Transfer Induces Therapeutic Angiogenesis by Recruiting Endothelial Progenitor Cells via the VEGF/eNOS Pathway
- Vitamin C Improves Attenuated Angiotensin II-Induced Endothelium-Dependent Vasodilation in Human Forearm Vessels
- FRS-117 An Initial Result of 2-Year Follow Up of 17 Clinical Cases With an NF-κ B Decoy Transfection at the Coronary Stenting(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis
- Identification of a novel gene involved in the pathogenesis of cardiac hypertrophy in rats
- HMG-CoA Reductase Inhibitor Limits Angiotensin II-Induced Progression and Destabilization of Established Atherosclerosis in ApoE-Knockout Mice through Its Cholesterol-Lowering Independent Actions
- Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice
- Anti-monocyte chemoattractant protein-1 gene therapy inhibits neointimal hyperplasia after balloon angioplasty in rats and monkeys
- Blockade of Vascular Endothelial Growth Factor Signals by sFLT-1 Gene Transer Attenuates Neointimal Hyperplasia after Perivascular Injury in Mice
- Monocyte Chemoattractant Protein-1 is Vital in Angiotensin II-induced Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice
- Pravastatill Attenuates Cardiovascular Inflammatory and Proliferative Changes in a Rat Model of Chronic Inhibition of Nitric Oxide Synthesis by Its Cholesterol-Lowering Independent Actions
- IS037 3-Hydroxyl-3-Methylglutaryl(HMG)-CoA Reductase Inhibitors Attenuate Cardiovascular Inflammatory Changes and Cardiovascular Remodeling in a Rat Model of Chronic Inhibition of NO Synthesis
- IS010 3-Hydroxyl-3-Methylgutaryl(HMG)-CoA Reductase Inhibitors Attenuate Inflammatory and Proliferative Changes of Rat Hearts and Vessels Induced by Chronic Inhibition of NO Synthesis
- Anti-inflammation Strategy Via Local Gene Transfer with Geneeluting Stents Attenuates in-stent Restenosis in Hypercholesterolemic Rabbits and Monkeys(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 16 (IHD), The 69th Annual Scientific Mee
- PE-318 Vascular Endothelial Growth Factor is an Essential Mediator in the Development of Angiotensin II-induced Arteriosclerosis(Atherosclerosis, Basic 4 (IHD) : PE54)(Poster Session (English))
- OE-123 Blockade or Abrogation of Angiotensin II AT1 Receptor Suppressed Accelerated Diabetic Atherosclerosis in Streptozotosin-Induced Diabetic Apolipoprotein E-Deficient Mice(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
- OE-120 Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin in nonhuman primates(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
- Upregulation of Monocyte Chemoattractant Protein (MCP)-1 Receptor in Circulating Monocytes Contributes to Angiotensin II : Induced Arteriosclerosis/Atherosclerosis
- Soluble FLt-1 Gene Transfer Attenuates Neointimal Hyperplasia after Perivascular Injury in Apoliporotein-E Knockout Mice
- Enhanced Expression of MCP-1 Receptor in Circulating Monocytes in Hypertensive Patients through Angiotensin II Type 1 Receptor
- OE-064 Critical Role of Angiotensin II AT1 Signals in Vascular Senescence in Atherogenesis(Atherosclerosis, basic-1 (H) OE11,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Angiotensin II AT1 Receptor-Mediated Enhanced RAGE Signals are Responsible for the Mechanism of Accerelated Atherosclerosis by Diabetes Mellitus(Atherosclerosis, Basic 10 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OE-183 A New Drug Delivery System Using Fibronectin-VEGF Fusion is More Effective and Harmless than VEGF Alone for the Therapeutic Neovascularization(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japane
- cAMP-Response Element-Binding Protein Mediates Prostaglandin F_2α-Induced Hypertrophy of Vascular Smooth Muscle Cells
- Suppression of Neointimal Formation in a Canine Model of Vein Graft Disease by Adenovirus-Mediated Anti Monocyte Chemoattractant Protein-1 Gene Therapy(Gene Therapy 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Coronary Vascular K+ATP Channels Contribute to the Maintenance of Myocardial Perfusion in Dogs With Pacing-Induced Heart Failure
- Gene Therapy Targeting Monocyte Chemoattractant Protein-1 For Vascular Disease
- Blockade of Vascular Endothelial Growth Factor Attenuates Experimental Restenosis after Intraluminal Injury
- 2 Stent-Based Local Delivery of Nuclear Factor-k B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits(Young Investigator's Award Finalists Lecture (YIA),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Attenuates Stent-associated Neointimal Formation in Hypercholesterolemic Non-human Primates (Restenosis after Angioplasty, Basic/Clinical 6 (IHD), The 69th Annual Scienti
- A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Attenuates Atherosclerosis Through Antioxidant Actions in Hypercholesterolemic Mice and Monkeys(Atherosclerosis, Basic 5 (IHD), The 69th Annual Scientific Meeting of the
- Catheter-based Adenovirus-mediated Local Gene Transfer of Anti-inflammation Factor Attenuates In-stent Neointimal Formation in Non-human Primates(Restenosis after Angioplasty, Basic/Clinical 5 (IHD), The 69th Annual Scientific Meeting of the Japanese Circ
- OE-121 Absence of monocyte chemoattractant protein-1 receptor CCR2 on monocytes supresses angiotensin II-induced progression of atherosclerosis in ApoE-deficient mice(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
- FRS-166 Stent-based delivery of nuclear factor-κB(NF-κB) attenuates in-stent restenosis in hypercholesterolemic rabbits(Coronary Heart Disease : Basic Science (IHD) : FRS20)(Featured Research Session (English))
- Anti-Monocyte Chemoattractant Protein-1 Therapy Reduces Experimental In-Stent Restenosis in Hypercholesterolemic Rabbits
- A gene therapy targeting early growth response factor-1 by "decoy" strategy inhibits neointinal hyperplasia in hypercholesterolemic rabbits
- Pioglitazone prevents Coronary Arteriosclerosis through inhibition of inflammation by downregulation of monocyte CCR2 in Rat
- 3 Development of a Novel Bioabsorbable Polymeric Nanoparticle-Eluting Stent by an Actively-Controlled Multilayer Coating Technology(What is New Nano-Technology in the Cardio-vascular Medicine?, The 71st Annual Scientific Meeting of the Japanese Circulatio
- Clinical Importance of Endothelial Function in Arteriosclerosis and Ischemic Heart Disease
- The Role of VEGF System in Restenosis and Arteriosclerosis
- 3 Anti-Monocyte Chemoattractant Protein-1 (MCP-1) Therapy Against Restenosis(Plenary Session 4 (PL4) (IHD) : Restenosis after PCI 2003 : New Therapies for the Next Generation)(Special Program)
- Bone Marrow-derived Monocyte Chemoattractant Protei-1 Receptor CCR2 is Critical in Angiotensin II-induced Vascular Remodeling and Atherosclerotic Process(Recent Advance in the Role of Renin-Angiotensin-Aldosterone System in Atherosclerotic Vascular Diseas
- 4 Nanoparticle-mediated Endothelial Cell-selective Delivery of Pitavastatin Induces Therapeutic Neovascularization(Latest Development of Nanotechnology Revolutionizes Treatments of Cardiovascular Diseases,Topic 3 (TP-3) (H),The 73rd Annual Scientific Meet
- Local Gene Transfer via Gene-Eluting Stents for Prevention of Restenosis : An Anti-inflammation Strategy for Next-Generation Intravascular Therapy(New Technologies in the Drug-Eluting Stent Era, The 69th Annual Scientific Meeting of the Japanese Circulati
- Novel anti-MCP-1 gene therapy against restenosis and atherosclerosis
- Anti-monocyte chemoattractant protein-1 gene therapy protects against experimental autoimmune myocarditis
- Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction
- Peroxisome proliferator-activated receptor y activator attenuates left ventricular remodeling and failure after experimental myocardial infarction
- Stress and Vascular Responses: Anti-inflammatory Therapeutic Strategy Against Atherosclerosis and Restenosis After Coronary Intervention